Elevance Health Inc. (ELV) financial statements and ratios from SEC XBRL: revenue $202.4B (TTM), net margin 2.8%, revenue growth 9.5% YoY, P/E 14.1. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $199.13B |
| Revenue (TTM) | $202.4B |
| Net Margin | 2.8% |
| Operating Margin (TTM) | 2.2% |
| Revenue Growth (YoY) | 9.5% |
| EPS Growth (YoY) | 34.2% |
| FCF Growth (YoY) | -154.4% |
| P/E Ratio | 14.1 |
| EV / EBITDA | 11.4 |
| Price / Book | 1.94 |
| Price / Sales | 0.43 |
| FCF Yield | 19.8% |
| Altman Z-Score | 3.15 (safe) |
| Piotroski F-Score | 6/9 |
| Piotroski checks passed | 6 of 9 |
| Industry P/E (Insurance) | 13.1 |
| Sector P/E (Healthcare) | 21.7 |
ELV overview · ELV earnings · ELV KPIs · ELV documents · ELV ownership · ELV peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.